Publisher
Springer Berlin Heidelberg
Reference21 articles.
1. Altea Therapeutics (2008)
http://www.alteatherapeutics.com
2. Bouwstra JA, Ponec M (2006) The skin barrier in healthy and diseased state. Biochim Biophys Acta 1758:2080–2095
3. Cork MJ, Robinson DA, Vasilopoulos Y, Ferguson A, Moustafa M, MacGowan A, Duff GW, Ward SJ, Tazi-Ahnini R (2006) New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions. J Allergy Clin Immunol 118:3–21
4. Delgado-Charro MB, Guy RH (2001) Transdermal drug delivery. In: Hillery AM, Lloyd AW, Swarbrick J (eds) Drug Delivery and Targeting for Pharmacists and Pharmaceutical Scientists. Harwood Academic Publishers, London, pp 207–236
5. Dmochowski RR, Sand PK, Zinner NR, Gittelman MC, Davila GW, Sanders SW, Transdermal Oxybutynin Study Group (2003) Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology 62:237–242
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献